Atea Pharmaceuticals, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
BLACKROCK, INC. | 05/02/2025 | 8.94 M | $26.74 M | -1.31% | 10.50% |
BML CAPITAL MANAGEMENT, LLC | 05/07/2025 | 7.61 M | $22.75 M | 0.02% | 8.94% |
FMR LLC | 05/12/2025 | 6.02 M | $17.99 M | -6.34% | 7.07% |
TANG CAPITAL MANAGEMENT LLC | 05/15/2025 | 4.80 M | $14.35 M | 0.23% | 5.64% |
VANGUARD GROUP INC | 05/09/2025 | 4.73 M | $14.14 M | 1.30% | 5.55% |
BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 05/15/2025 | 2.49 M | $7.43 M | 0.00% | 2.92% |
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 1.98 M | $5.91 M | 3.16% | 2.32% |
STATE STREET CORP | 05/15/2025 | 1.77 M | $5.29 M | -0.86% | 2.08% |
RENAISSANCE TECHNOLOGIES LLC | 05/14/2025 | 1.28 M | $3.82 M | 5.08% | 1.50% |
DIMENSIONAL FUND ADVISORS LP | 05/13/2025 | 1.18 M | $3.54 M | 21.10% | 1.39% |
ACADIAN ASSET MANAGEMENT LLC | 05/21/2025 | 917.85 K | $2.74 M | -1.62% | 1.08% |
JPMORGAN CHASE & CO | 05/12/2025 | 773.22 K | $2.31 M | 88.93% | 0.91% |
NORTHERN TRUST CORP | 05/13/2025 | 690.18 K | $2.06 M | -2.09% | 0.81% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 607.88 K | $1.82 M | -7.83% | 0.71% |
FEDERATED HERMES, INC. | 05/08/2025 | 582.73 K | $1.74 M | -0.04% | 0.68% |
NEWTYN MANAGEMENT, LLC | 05/15/2025 | 580.00 K | $1.73 M | 0.00% | 0.68% |
TWO SIGMA ADVISERS, LP | 05/15/2025 | 533.00 K | $1.59 M | 7.98% | 0.63% |
CM MANAGEMENT, LLC | 05/09/2025 | 500.00 K | $1.50 M | 66.67% | 0.59% |
MORGAN STANLEY | 05/15/2025 | 455.34 K | $1.36 M | -19.70% | 0.53% |
04/30/2025 | 452.06 K | $1.35 M | 37.58% | 0.53% | |
BANQUE PICTET & CIE SA | 04/30/2025 | 345.08 K | $1.03 M | 0.00% | 0.41% |
D. E. SHAW & CO., INC. | 05/15/2025 | 344.55 K | $1.03 M | 34.54% | 0.40% |
WELLINGTON MANAGEMENT GROUP LLP | 05/13/2025 | 304.53 K | $910.55 K | 39.37% | 0.36% |
05/12/2025 | 291.09 K | $870.36 K | 100.00% | 0.34% | |
GOLDMAN SACHS GROUP INC | 06/27/2025 | 258.61 K | $773.24 K | -17.15% | 0.30% |
TWO SIGMA INVESTMENTS, LP | 05/15/2025 | 251.75 K | $752.73 K | -11.95% | 0.30% |
BANK OF NEW YORK MELLON CORP | 04/29/2025 | 203.12 K | $607.32 K | -4.20% | 0.24% |
HSBC HOLDINGS PLC | 05/14/2025 | 201.23 K | $603.70 K | 24.06% | 0.24% |
AUOUR INVESTMENTS LLC | 05/01/2025 | 177.00 K | $522.15 K | 0.00% | 0.21% |
INVESCO LTD. | 05/12/2025 | 173.16 K | $517.74 K | -11.97% | 0.20% |
BARCLAYS PLC | 05/15/2025 | 171.31 K | $512.00 K | -14.39% | 0.20% |
AMERICAN CENTURY COMPANIES INC | 05/13/2025 | 162.86 K | $486.95 K | 12.17% | 0.19% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 05/15/2025 | 143.10 K | $427.87 K | 329.73% | 0.17% |
ALLIANCEBERNSTEIN L.P. | 05/15/2025 | 119.22 K | $356.47 K | 0.00% | 0.14% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 05/15/2025 | 118.17 K | $353.32 K | -69.77% | 0.14% |
RHUMBLINE ADVISERS | 05/29/2025 | 116.44 K | $348.15 K | -10.29% | 0.14% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 105.58 K | $315.70 K | 104.79% | 0.12% |
STRS OHIO | 05/28/2025 | 105.50 K | $315.45 K | 0.00% | 0.12% |
JANE STREET GROUP, LLC | 05/19/2025 | 102.61 K | $306.80 K | 80.36% | 0.12% |
STATE OF WISCONSIN INVESTMENT BOARD | 05/15/2025 | 98.13 K | $293.40 K | -15.41% | 0.12% |
BNP PARIBAS ARBITRAGE, SNC | 05/14/2025 | 84.36 K | $252.24 K | -12.52% | 0.10% |
PRICE T ROWE ASSOCIATES INC /MD/ | 05/14/2025 | 79.91 K | $239.00 K | 8.16% | 0.09% |
MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 76.56 K | $228.92 K | 240.18% | 0.09% |
HIGHTOWER ADVISORS, LLC | 05/13/2025 | 75.09 K | $224.51 K | 49.92% | 0.09% |
MACQUARIE GROUP LTD | 05/15/2025 | 70.00 K | $209.00 K | 0.00% | 0.08% |
UBS GROUP AG | 05/13/2025 | 63.57 K | $190.07 K | -12.82% | 0.07% |
SHAY CAPITAL LLC | 05/15/2025 | 61.12 K | $182.76 K | 99.54% | 0.07% |
BANK OF AMERICA CORP /DE/ | 05/15/2025 | 60.66 K | $181.38 K | -17.40% | 0.07% |
DEUTSCHE BANK AG\ | 05/09/2025 | 60.26 K | $180.19 K | 100.00% | 0.07% |
RUSSELL INVESTMENTS GROUP, LTD. | 05/13/2025 | 54.90 K | $164.16 K | 10,793.25% | 0.06% |
Atea Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 114 institutional investors and hedge funds held shares of Atea Pharmaceuticals, Inc.. The most heavily invested institutionals were:
BlackRock, Inc.: 8.94 M
BML Capital Management, LLC: 7.61 M
FMR LLC: 6.02 M
TANG CAPITAL MANAGEMENT LLC: 4.8 M
VANGUARD GROUP INC: 4.73 M
Bain Capital Life Sciences Investors, LLC: 2.49 M
61.33% of Atea Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 62.00 M shares in the last 24 months. This purchase volume represents approximately $212.65 M in transactions.